207 related articles for article (PubMed ID: 24058569)
1. Leucine-rich α2-glycoprotein is a novel biomarker of neurodegenerative disease in human cerebrospinal fluid and causes neurodegeneration in mouse cerebral cortex.
Miyajima M; Nakajima M; Motoi Y; Moriya M; Sugano H; Ogino I; Nakamura E; Tada N; Kunichika M; Arai H
PLoS One; 2013; 8(9):e74453. PubMed ID: 24058569
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of CSF biomarker profile in idiopathic normal pressure hydrocephalus; leucine-rich α-2-glycoprotein is a potential biological marker].
Nakajima M; Arai H; Miyajima M
Rinsho Shinkeigaku; 2010 Nov; 50(11):973-6. PubMed ID: 21921531
[TBL] [Abstract][Full Text] [Related]
3. Leucine-rich α-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus.
Nakajima M; Miyajima M; Ogino I; Watanabe M; Miyata H; Karagiozov KL; Arai H; Hagiwara Y; Segawa T; Kobayashi K; Hashimoto Y
Acta Neurochir (Wien); 2011 Jun; 153(6):1339-46; discussion 1346. PubMed ID: 21336807
[TBL] [Abstract][Full Text] [Related]
4. Disease-Specific Changes in Reelin Protein and mRNA in Neurodegenerative Diseases.
Lidón L; Urrea L; Llorens F; Gil V; Alvarez I; Diez-Fairen M; Aguilar M; Pastor P; Zerr I; Alcolea D; Lleó A; Vidal E; Gavín R; Ferrer I; Del Rio JA
Cells; 2020 May; 9(5):. PubMed ID: 32438605
[TBL] [Abstract][Full Text] [Related]
5. Elevated CSF LRG and Decreased Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
Vanninen A; Nakajima M; Miyajima M; Rauramaa T; Kokki M; Musialowicz T; Mäkinen PM; Herukka SK; Koivisto AM; Jääskeläinen JE; Hiltunen M; Leinonen V
J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33800840
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A
J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256
[TBL] [Abstract][Full Text] [Related]
7. Brain localization of leucine-rich α2-glycoprotein and its role.
Nakajima M; Miyajima M; Ogino I; Watanabe M; Hagiwara Y; Segawa T; Kobayashi K; Arai H
Acta Neurochir Suppl; 2012; 113():97-101. PubMed ID: 22116432
[TBL] [Abstract][Full Text] [Related]
8. Leucine-rich α2-glycoprotein overexpression in the brain contributes to memory impairment.
Akiba C; Nakajima M; Miyajima M; Ogino I; Miura M; Inoue R; Nakamura E; Kanai F; Tada N; Kunichika M; Yoshida M; Nishimura K; Kondo A; Sugano H; Arai H
Neurobiol Aging; 2017 Dec; 60():11-19. PubMed ID: 28917663
[TBL] [Abstract][Full Text] [Related]
9. Analysis of potential diagnostic biomarkers in cerebrospinal fluid of idiopathic normal pressure hydrocephalus by proteomics.
Li X; Miyajima M; Mineki R; Taka H; Murayama K; Arai H
Acta Neurochir (Wien); 2006 Aug; 148(8):859-64; discussion 864. PubMed ID: 16755327
[TBL] [Abstract][Full Text] [Related]
10. Leucine-rich alpha-2 glycoprotein in the cerebrospinal fluid is a potential inflammatory biomarker for meningitis.
Chong PF; Sakai Y; Torisu H; Tanaka T; Furuno K; Mizuno Y; Ohga S; Hara T; Kira R
J Neurol Sci; 2018 Sep; 392():51-55. PubMed ID: 30097155
[TBL] [Abstract][Full Text] [Related]
11. Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus-like magnetic resonance imaging features.
Ohara M; Hattori T; Yokota T
Eur J Neurol; 2020 Oct; 27(10):1930-1936. PubMed ID: 32416639
[TBL] [Abstract][Full Text] [Related]
12. Expression of TGF-betas and TGF-beta type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus.
Li X; Miyajima M; Jiang C; Arai H
Neurosci Lett; 2007 Feb; 413(2):141-4. PubMed ID: 17194537
[TBL] [Abstract][Full Text] [Related]
13. Clusterin CSF levels in differential diagnosis of neurodegenerative disorders.
Přikrylová Vranová H; Hényková E; Mareš J; Kaiserová M; Menšíková K; Vaštík M; Hluštík P; Zapletalová J; Strnad M; Stejskal D; Kaňovský P
J Neurol Sci; 2016 Feb; 361():117-21. PubMed ID: 26810527
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
[TBL] [Abstract][Full Text] [Related]
15. Serum leucine-rich α2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson's disease.
Ohmichi T; Kasai T; Shinomoto M; Kitani-Morii F; Fujino Y; Menjo K; Mizuno T
PLoS One; 2023; 18(2):e0282153. PubMed ID: 36812242
[TBL] [Abstract][Full Text] [Related]
16. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
Jeppsson A; Wikkelsö C; Blennow K; Zetterberg H; Constantinescu R; Remes AM; Herukka SK; Rauramaa T; Nagga K; Leinonen V; Tullberg M
J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1117-1123. PubMed ID: 31167811
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration.
Höglund K; Schussler N; Kvartsberg H; Smailovic U; Brinkmalm G; Liman V; Becker B; Zetterberg H; Cedazo-Minguez A; Janelidze S; Lefevre IA; Eyquem S; Hansson O; Blennow K
Neurobiol Dis; 2020 Feb; 134():104645. PubMed ID: 31669672
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid neurofilament light chain as a biomarker of neurodegeneration in the Tg4510 and MitoPark mouse models.
Clement A; Mitchelmore C; Andersson DR; Asuni AA
Neuroscience; 2017 Jun; 354():101-109. PubMed ID: 28461218
[TBL] [Abstract][Full Text] [Related]
19. Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
Jingami N; Uemura K; Asada-Utsugi M; Kuzuya A; Yamada S; Ishikawa M; Kawahara T; Iwasaki T; Atsuchi M; Takahashi R; Kinoshita A
J Alzheimers Dis; 2019; 72(1):271-277. PubMed ID: 31561378
[TBL] [Abstract][Full Text] [Related]
20. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.
Craig-Schapiro R; Perrin RJ; Roe CM; Xiong C; Carter D; Cairns NJ; Mintun MA; Peskind ER; Li G; Galasko DR; Clark CM; Quinn JF; D'Angelo G; Malone JP; Townsend RR; Morris JC; Fagan AM; Holtzman DM
Biol Psychiatry; 2010 Nov; 68(10):903-12. PubMed ID: 21035623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
